As part of our research programme, we fund exceptional candidates from stroke professional backgrounds to our prestigious Postgraduate and Postdoctoral Fellowship positions. Meet our new fellows for 2017.
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.
The first day of the European Stroke Organisation Conference (ESOC) 2017 in Prague included some truly inspiring scientific sessions. These included reporting from the DAWN study which suggests that more patients could be able to receive mechanical thrombectomy after stroke.
To help plan the care of stroke survivors and their rehabilitation, health professionals usually use a scale called the Barthel Index (BI) to measure how well they can perform activites of daily living (ADLs).
On December 5, 2014, Emma Patchick one of our Postgaduate Fellows, published a research paper online in the medical journal, Health Expectations.
Thousands of people are at risk of stroke because they fail to recognise the signs of a Transient Ischaemic Attack (TIA, also known as mini-stroke), according to the findings of a new poll(i) launched today on World Stroke Day (29 October 2012).
A new report published today shows that stroke research remains severely underfunded compared to the devastating impact it has on people’s lives. The UK Health Research Analysis 2018 also shows stroke research receives much less funding than many other areas of health research.
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after a brain haemorrhage.
This study will investigate whether early initiation of direct anticoagulant drugs will be as safe as later initiation in stroke patients with an abnormal heart rhythm (atrial fibrillation). It will also investigate whether early initiation could lead to fewer recurrent strokes.